Stifel Nicolaus Issues Pessimistic Forecast for agilon health (NYSE:AGL) Stock Price

agilon health (NYSE:AGL) had its price objective reduced by stock analysts at Stifel Nicolaus from $7.00 to $2.00 in a report issued on Tuesday,Benzinga reports. The firm presently has a “hold” rating on the stock. Stifel Nicolaus’ target price suggests a potential upside of 6.10% from the stock’s previous close.

AGL has been the subject of a number of other reports. Royal Bank of Canada restated an “outperform” rating and set a $8.00 price objective on shares of agilon health in a research note on Wednesday, August 7th. Citigroup reaffirmed a “sell” rating and issued a $2.50 price objective (down from $7.00) on shares of agilon health in a research report on Tuesday, October 29th. William Blair lowered agilon health from an “outperform” rating to a “market perform” rating in a report on Friday, November 8th. TD Cowen lowered their price target on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday. Finally, Benchmark reissued a “buy” rating and issued a $9.00 target price on shares of agilon health in a research report on Thursday, August 8th. Three investment analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the stock. According to data from MarketBeat.com, agilon health presently has a consensus rating of “Hold” and an average price target of $6.38.

agilon health Trading Up 0.8 %

NYSE:AGL opened at $1.89 on Tuesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health has a one year low of $1.80 and a one year high of $13.76. The company’s 50-day simple moving average is $3.18 and its 200 day simple moving average is $4.93.

agilon health (NYSE:AGL) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) earnings per share for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same quarter in the previous year, the company earned ($0.06) EPS. As a group, equities analysts anticipate that agilon health will post -0.35 earnings per share for the current fiscal year.

Insider Activity

In other agilon health news, CEO Steven Sell acquired 20,000 shares of the company’s stock in a transaction on Thursday, September 12th. The shares were bought at an average cost of $3.36 per share, for a total transaction of $67,200.00. Following the completion of the purchase, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 0.00 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 3.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. J.Safra Asset Management Corp grew its stake in shares of agilon health by 626.1% in the second quarter. J.Safra Asset Management Corp now owns 4,204 shares of the company’s stock valued at $27,000 after buying an additional 3,625 shares in the last quarter. CWM LLC raised its stake in shares of agilon health by 406.5% in the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares in the last quarter. Nisa Investment Advisors LLC acquired a new stake in agilon health during the second quarter valued at approximately $60,000. Bleakley Financial Group LLC acquired a new stake in shares of agilon health during the first quarter worth $65,000. Finally, Allspring Global Investments Holdings LLC lifted its position in shares of agilon health by 17,790.0% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 10,734 shares of the company’s stock valued at $70,000 after acquiring an additional 10,674 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.